JP Morgan Chase’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
79,900
+7,900
+11% +$187K ﹤0.01% 4309
2025
Q4
$2.34M Sell
72,000
-117,200
-62% -$5.02M ﹤0.01% 3962
2025
Q3
$10.7M Buy
189,200
+188,900
+62,967% +$9.68M ﹤0.01% 2651
2025
Q2
$15K Buy
+300
New +$13.6K ﹤0.01% 6238
2024
Q3
Sell
-50,000
Closed -$1.01M 7522
2024
Q2
$1.01M Buy
+50,000
New +$832K ﹤0.01% 4276
2021
Q4
Sell
-2,100
Closed -$16K 6774
2021
Q3
$16K Buy
+2,100
New +$17.8K ﹤0.01% 6090

Other funds holding HIMS

JP Morgan Chase's HIMS Position: Q1 2026 in Review

JP Morgan Chase reduced its Hims & Hers Health (HIMS) stake by 72% in Q1 2026, selling an estimated $321M and leaving 5,240,816 shares worth $98.4M. The position accounts for 0.01% of the portfolio, ranked #992.

JP Morgan Chase first reported a position in HIMS in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.01B in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • JP Morgan Chase held 5,240,816 shares of Hims & Hers Health worth $98.4M as of Q1 2026.
  • JP Morgan Chase sold 13,597,454 Hims & Hers Health shares in Q1 2026, an estimated $321M.
  • Hims & Hers Health made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #992 holding.
  • JP Morgan Chase first reported a position in Hims & Hers Health in Q3 2020 and has held it in 21 quarters since.
  • JP Morgan Chase's Hims & Hers Health position peaked at $1.01B in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.